Innovative drug concept rebounds from bottoming out, Haofan Biology rises nearly 10%

The concept of innovative drugs hit a bottom and rebounded in the intraday trading, Hao Fan Biological rose by nearly 10%, Ha Sanlian touched the daily limit, Duorui Pharmaceuticals, Zhixiang Jintai, Haisike, Borui Pharmaceuticals, Medice etc. followed the rise.